Skip to content
Search

Latest Stories

Sigma Pharmaceuticals partners with BoxxDocks to boost efficiency and sustainability

Sigma Pharmaceuticals partners with BoxxDocks to boost efficiency and sustainability

Through this partnership, Sigma aims to bolster its ESG strategy and accelerate its commitment to NHS net zero objectives

Sigma Pharmaceuticals, a leading pharmacy wholesaler and distributor in the UK, has joined hands with logistics technology innovator, BoxxDocks, to enhance efficiency and sustainability across its warehouse and transport operations.


Through this collaboration, Sigma will pioneer the use of BoxxDocks' cutting-edge tracking technology in the pharmaceutical sector, thereby improving asset visibility and management, a first-of-its-kind initiative in the industry.

Considered to be the first of its kind in the supply chain and logistics industry, BoxxDocks’ technology offers data-driven, granular track and trace solutions that “not only addresses the critical issue of inventory loss but also paves the way for cost savings and environmental benefits.”

By providing real-time data on asset location and movement, it empowers B2B distributors to “map their entire supply chains with unprecedented accuracy and efficiency.” This capability can significantly enhance operational efficiency and reduce costs by optimising asset utilisation and minimising loss, the company noted.

Rajiv Shah, Procurement and Innovation Officer at Sigma, said that the partnership with BoxxDocks will help accelerate their commitment to sustainability and achieving NHS net zero objectives.

“By having the ability to track our assets, we'll be able to minimise our environmental footprint by significantly reducing single-use materials, cutting down on the use of disposable packaging, while streamlining our distribution processes,” he added.

Additionally, BoxxDocks' innovative tracking technology enhances transit security and reduces waste by promoting reusable assets over single-use materials, thereby cutting environmental and financial impacts.

BoxxDocks CEO Alessandro Attanzio emphasised that their mission is to help enhance B2B distribution by offering smart, sustainable and cost-saving solutions.

He said: “We’re delighted to be working with Sigma Pharmaceuticals, which is a forward-thinking company with a passion for innovation that rivals our own. We look forward to continuing our journey of innovation together, demonstrating a model of best practice for pharma distribution.”

By partnering with Sigma, Attanzio said they have further refined their technology to meet the specific needs of the pharmaceutical sector.

Attanzio reiterated that their technology can “transform operations, reduce cost and environmental impact, and help drive the industry forward to meet efficiency and sustainability goals.”

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less